ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,996Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 236

$639K Total Retail Price of All Prescriptions

Rank: 14 out of 236

553 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 553 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

17% of this provider’s 553 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

4% of this provider’s 8,640 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $114 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
FUROSEMIDE 665 542 1 1
SIMVASTATIN 478 406 2 7
CALCITRIOL 462 411 3 4
HYDROCODONE-ACETAMINOPHEN 370 225 S3 4 20
CARVEDILOL 324 263 5 10
LISINOPRIL 314 255 6 3
AMLODIPINE BESYLATE 307 263 7 2
LEVOTHYROXINE SODIUM 291 253 8 17
GUANFACINE HCL 250 219 R 9 78
WARFARIN SODIUM 246 227 10 24
OMEPRAZOLE 200 163 11 16
POTASSIUM CHLORIDE 192 148 12 25
METOPROLOL TARTRATE 182 137 13 8
DIOVAN HCT 138 121 14 86
METFORMIN HCL 138 106 14 33
ALLOPURINOL 138 97 14 9
PANTOPRAZOLE SODIUM 136 116 17 44
DIOVAN 134 117 18 23
CLOPIDOGREL 125 114 19 48
ATENOLOL 124 124 20 26
TAMSULOSIN HCL 120 108 21 42
DONEPEZIL HCL 114 103 22 54
ZOLPIDEM TARTRATE 113 61 23 55
ATORVASTATIN CALCIUM 110 85 24 21
METOLAZONE 101 59 25 60
CITALOPRAM HBR 100 86 26 51
GABAPENTIN 96 89 27 36
ROPINIROLE HCL 95 66 28 93
PLAVIX 95 90 28 61
PREDNISONE 88 48 30 19
TRAMADOL HCL 84 41 31 35
GLIPIZIDE 83 68 32 47
LEVOFLOXACIN 82 53 33 91
ALENDRONATE SODIUM 78 78 34 41
ADVAIR DISKUS 73 50 35 87
LOSARTAN POTASSIUM 69 47 36 15
LANTUS 65 28 37 46
HUMALOG 65 24 37 89
METOPROLOL SUCCINATE 64 53 39 14
FENOFIBRATE 62 48 40 67
LOVASTATIN 61 57 41 49
TRICOR 60 58 42 83
AZITHROMYCIN 60 49 42 75
NAMENDA 60 60 42 74
FENTANYL 59 38 S2 45 125
COLCRYS 59 53 45 113
ENALAPRIL MALEATE 59 53 45 32
HYDROMORPHONE HCL 57 0 S2 48 157
KLOR-CON M20 57 44 48 57
LIPITOR 55 54 50 126
SPIRONOLACTONE 54 24 51 27
AMITRIPTYLINE HCL 54 32 R 51 129
BYSTOLIC 53 52 53 97
ISOSORBIDE MONONITRATE ER 53 49 53 53
HYDROCHLOROTHIAZIDE 51 40 55 18
PAROXETINE HCL 50 40 56 76
PRADAXA 50 50 56 180
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 14, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.